Resistin-like β (RETNLB), a member of the resistin family of proteins, plays a pivotal role in the regulation of inflammation and has been implicated in the modulation of several cellular processes including immunity and metabolism. This protein, primarily expressed in various tissues such as adipose tissue, lung, and gastrointestinal tract, is involved in the intricate network of cytokines and factors that govern the body's inflammatory response. RETNLB functions through its interaction with specific receptors on the surface of target cells, initiating signaling cascades that culminate in the activation of transcription factors and the expression of genes involved in the inflammatory process. The precise mechanisms through which RETNLB exerts its effects are complex and involve a multitude of signaling pathways, highlighting its significance in maintaining the balance between pro-inflammatory and anti-inflammatory responses within the body.
The activation of RETNLB involves various cellular and molecular mechanisms that enhance its expression and function. Such activation can be triggered by specific stimuli, including inflammatory cytokines, microbial products, and other stress-related signals, which lead to the upregulation of RETNLB expression and secretion. Upon its release, RETNLB interacts with its receptors on target cells, activating intracellular signaling pathways such as the NF-κB pathway, which is crucial for the transcription of genes associated with inflammation. Furthermore, the activation of RETNLB can also be facilitated by post-translational modifications that enhance its stability, secretion, or activity. These modifications, including phosphorylation, glycosylation, and cleavage, play critical roles in regulating the bioavailability and efficacy of RETNLB as a mediator of inflammation. Through these diverse mechanisms of activation, RETNLB exerts a substantial impact on the cellular and physiological processes related to inflammation, underscoring its importance in the body's response to pathological conditions and stress.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates intracellular cAMP, which may indirectly enhance Resistin-like β activity through protein kinase A (PKA)-mediated signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, IBMX increases cAMP levels, potentially enhancing Resistin-like β activity via the cAMP/PKA pathway. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Interacts with E-prostanoid receptors and via cAMP signaling, may indirectly increase Resistin-like β activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β leading to Wnt/β-catenin pathway activation, which may increase the expression and activity of Resistin-like β. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can upregulate Resistin-like β by increasing the acetylation of histones near the RETNLB gene. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An Nrf2 activator, sulforaphane may enhance the expression of Resistin-like β by influencing antioxidant response elements in the RETNLB promoter. | ||||||
Chitosan | 9012-76-4 | sc-221421 sc-221421A sc-221421B sc-221421D sc-221421C | 10 g 25 g 100 g 8 kg 500 g | $41.00 $55.00 $135.00 $3339.00 $298.00 | 6 | |
May enhance Resistin-like β activity by modulating macrophage polarization and thus influencing cytokine production and signaling pathways related to RETNLB expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1 which is known to influence PPARγ activity, potentially leading to increased Resistin-like β levels. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
Agonist for PPARα which may indirectly enhance Resistin-like β activity by modulating lipid metabolism and influencing RETNLB expression. | ||||||